Unibest
← Back to patent-cliff list

CAS 160844-75-7

ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Codes: FEBU-008

Application context (from source-drug indications)

HyperuricaemiaFebuxostatGoutFebuxostatIntracranial haemorrhageFebuxostatUlcerative colitisFebuxostatChronic renal impairmentFebuxostatPainFebuxostat

Source drugs (routes using this intermediate)

DrugTierExpiry
FebuxostatTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

FebuxostatOptimised routesteps: 8total yield: /
FebuxostatOptimised routesteps: 5total yield: 1.29 g

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API WorksEthyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP SiteEthyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.